There were 1,849 press releases posted in the last 24 hours and 447,396 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image